Omer Jamy - Concepedia

Author

Omer Jamy

University of Alabama at Birmingham ORCID

Also Known As

Jamy, Omer, O Jamy, OMER HASSAN JAMY, Omer H Jamy, Omer H. Jamy, Omer HASSAN Jamy, Omer Hassan Jamy, Omer Jamy, OmerH Jamy

185

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Alabama at Birmingham The University of Texas MD Anderson Cancer Center Medical College of Wisconsin University of Minnesota Cleveland Clinic

About

Omer Jamy is an author at University of Alabama at Birmingham specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	151
2	Public Health	2	2	33
3	Blood Transplantation	2	2	34
4	Health Sciences	1	1	22
5	Cellular Therapies	1	1	22

Omer Jamy

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis Javier Bolaños‐Meade, Mehdi Hamadani, Juan Wu, New England Journal of Medicine	2023	460
Adaptation of Remote Symptom Monitoring Using Electronic Patient-Reported Outcomes for Implementation in Real-World Settings Gabrielle B. Rocque, D’Ambra N. Dent, Stacey A. Ingram, JCO Oncology Practice	2022	54
Early complications after biliary enteric anastomosis for benign diseases: A retrospective analysis Syed Nabeel Zafar, Muhammad Rizwan Khan, Muhammad Nauman Khan, BMC Surgery	2011	53
Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil As the New Standard for Graft-Versus-Host Disease (GVHD) Prophylaxis in Reduced Intensity Conditioning: Results from Phase III BMT CTN 1703 Shernan G. Holtan, Mehdi Hamadani, Juan Wu, Blood	2022	52
Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial Yi‐Bin Chen, Mohamad Mohty, Robert Zeiser, Nature Medicine	2024	47
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR Matthew J. Wieduwilt, Wendy Stock, Anjali S. Advani, Leukemia	2021	39
Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis Smith Giri, Michelle Chi, Benny Johnson, Leukemia Research Hematological MalignancyLymphoid NeoplasiaOncologyMixed-phenotype Acute LeukemiaIndependent Predictor	2015	36
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis Guru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada‐Merly, Haematologica	2023	28
Clinical applications of the pedicled anterolateral thigh flap in penile reconstruction Mamoon Rashid, Ayesha Aslam, Saleem Malik, Journal of Plastic Reconstructive & Aesthetic Surgery UrologyClinical ApplicationsReconstructive SurgeryPenile ReconstructionSurgery	2011	27
Influence of Insurance and Marital Status on Outcomes of Adolescents and Young Adults With Acute Lymphoblastic Leukemia Andrew Fintel, Omer Jamy, Mike G. Martin Clinical Lymphoma Myeloma & Leukemia Family MedicineYoung AdultsHealth PolicyMarital StatusAcute Lymphoblastic Leukemia	2014	23

Page 1